Lazy: Created page with "There are a large number of drugs that were developed initially for various different purposes that subsequent laboratory research demonstrated to have significant anti-cancer properties. Given these old drugs have been used for years, have well-defined toxicity profiles, and are generally cheaper due to being off-patent, they offer the possibility of augmenting the benefits of the current standard treatment without significant additional toxicity. However, because their..."

2024-03-16T16:45:46Z

Created page with "There are a large number of drugs that were developed initially for various different purposes that subsequent laboratory research demonstrated to have significant anti-cancer properties. Given these old drugs have been used for years, have well-defined toxicity profiles, and are generally cheaper due to being off-patent, they offer the possibility of augmenting the benefits of the current standard treatment without significant additional toxicity. However, because their..."

New page

There are a large number of drugs that were developed initially for various different
purposes that subsequent laboratory research demonstrated to have significant
anti-cancer properties. Given these old drugs have been used for years, have well-defined
toxicity profiles, and are generally cheaper due to being off-patent, they offer the
possibility of augmenting the benefits of the current standard treatment without
significant additional toxicity. However, because their FDA approval is for different
purposes, many if not most neuro-oncologists have been reluctant to take advantage of
their possible benefits as components of a treatment cocktail. Some of these drugs have
been investigated as single agents for brain cancer treatment and some have also been
combined with the now standard Stupp protocol.

Category:RepurposedDrugs - Revision history